IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas

BACKGROUND: Epigenetic, genetic, and molecular studies have identified several diagnostic and prognostic markers in diffuse gliomas. Their importance for evaluating WHO grade II gliomas has yet to be specifically delineated. METHODS: We analyzed markers, including IDH mutation(IDHmut), 1p19q codelet...

Descripción completa

Detalles Bibliográficos
Autores principales: Leeper, Heather E., Caron, Alissa A., Decker, Paul A., Jenkins, Robert B., Lachance, Daniel H., Giannini, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745799/
https://www.ncbi.nlm.nih.gov/pubmed/26210286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745799/
https://www.ncbi.nlm.nih.gov/pubmed/26210286

Ejemplares similares